Maxwell RSC 48 DNA Extraction Systems or Equal – Commercial Blanket Purchase Agreement (BPA)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FOOD AND DRUG ADMINISTRATION
Contract Value
Not provided
Codes & Classification
Solicitation Number
HFP-2026-133524-75F40126Q00256
NAICS
334516 - Analytical Laboratory Instrument Manufacturing
Classification Code
H266
Additional Details
The U.S. Food and Drug Administration (FDA), under the Department of Health and Human Services (HHS), has issued a Combined Synopsis/Solicitation (Solicitation Number: HFP-2026-133524) for the establishment of a Commercial Blanket Purchase Agreement (BPA) to acquire Maxwell RSC 48 DNA Extraction Systems or equal products. This procurement is managed by the FDA’s Office of Acquisitions and Grants Services (OAGS) and is classified under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing), with Product Service Code H266.
Purpose and Scope:
The primary objective of this procurement is to equip FDA laboratory facilities with advanced DNA extraction systems that meet or exceed the performance and operational characteristics of the Maxwell RSC 48 platform. The BPA will cover the delivery, installation, on-site training, warranty support, and all related services necessary to ensure the effective deployment and sustained operation of these systems across multiple FDA laboratory locations. The intended outcome is to enhance the FDA’s laboratory capabilities in DNA extraction, supporting its mission in public health and regulatory science.
Key Requirements and Deliverables:
The contractor is responsible for providing all labor, materials, equipment, transportation, supervision, installation, training, warranty support, and incidental services required for the successful provision of the DNA extraction systems. Equal products are acceptable, provided they fully comply with the salient physical, functional, operational, and performance requirements detailed in the solicitation. Offerors proposing alternative solutions must submit comprehensive technical documentation to demonstrate compliance.
Key deliverables include:
- Delivery of DNA extraction systems to designated FDA laboratory facilities in Arkansas, Georgia, California, Colorado, Washington, and New York within 90 calendar days of order receipt.
- Completion of installation at each site within 14 calendar days following delivery.
- Provision of on-site training for FDA personnel.
- Warranty support and related post-installation services.
- All work is to be performed FOB Destination, with inspection and acceptance occurring at the delivery sites after successful installation, operational testing, and completion of training.
Contracting Entity and Location:
The contracting entity is the U.S. Food and Drug Administration, Office of Acquisitions and Grants Services. The primary place of performance is Jefferson, Arkansas, with additional FDA laboratory sites included in the scope of work. The primary point of contact for this solicitation is Michele Jackson, Contracting Officer ([email protected]).
Procurement Type and Special Considerations:
This solicitation is issued as a Request for Quotations (RFQ) and is being conducted under full and open competition; it is not set aside for small business concerns. The procurement follows the streamlined procedures for commercial products as outlined in FAR 12.202. The BPA will incorporate all applicable FAR and HHSAR clauses, including those related to installation, training, warranty, invoicing, and electronic payment.
Evaluation and Submission:
Award will be made using the Lowest Price Technically Acceptable (LPTA) source selection process. Proposals will be evaluated based on technical acceptability, past performance, and price. Offerors must ensure their submissions address all technical requirements and provide sufficient documentation for evaluation.
Key Dates:
- Questions regarding the solicitation are due by July 10, 2026, at 10:00 a.m. Eastern Time.
- Quotations must be submitted electronically by July 22, 2026, at 10:00 a.m. Eastern Time to the Contracting Officer.
Attachments to the solicitation include the full solicitation document, Performance Work Statement, Pricing Schedule, SF-18, Buy American Certificate, Past Performance Reference Form, and Technical Compliance Matrix. Interested contractors are advised to review all attachments for complete submission instructions and contract requirements.
This opportunity is suitable for contractors with proven experience in supplying, installing, and supporting advanced analytical laboratory instrumentation, particularly DNA extraction systems, and who can meet the FDA’s stringent technical and operational requirements across multiple locations.
Documents7